Q1 2021 Financial Highlights: Total net revenue was $16.2 million, nearly all of which was software-related revenue Gross margin was...
Culver City, Calif. – May 4, 2021 — NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses...
Q4 Financial Highlights 2020 vs 2019: Total revenue was $18.6 million Total software-related revenue was $18.6 million, up from $18.4 million...
Culver City, Calif. – February 22, 2021 — NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses...
New York, NY & El Segundo, CA – January 25, 2021: NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions...
NantHealth’s study data shows: Adoption of trastuzumab biosimilars in treatment of HER2-positive breast cancer is significant; does not appear to...
Study demonstrates the viability and value of RNA sequencing from formalin fixed samples in gaining a deeper understanding of patient...
Q3 2020 Financial Highlights: Total net revenue was $18.8 million, up from $18.6 million Total software-related revenue increased to $18.7...
Culver City, Calif. – October 30, 2020 — NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses...
NantHealth, ImmunityBio and NantOmics Presented Results at the 2020 AACR Virtual Special Conference: Pancreatic Cancer Culver City, CA – October...
Move Reinforces NantHealth’s Commitment to Improved Connectivity For Payers, Providers, and Revenue Cycle Organizations Culver City, CA – September 23,...
Expansion gives providers a fast and intuitive solution with comprehensive health plan access Culver City, CA – September 22, 2020...
